Fujian Akeylink Biotechnology Co., Ltd.
Clinical trials sponsored by Fujian Akeylink Biotechnology Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo aims to silence hepatitis b virus Results expected Oct 2026 (estimated)
- New pill could help hepatitis b patients who Don't respond to standard care Results expected Dec 2026 (estimated)